Iatrogenic Alogenosis Due to the Use of Biopolymers

Added to this is the growing number of these products that do not meet the standards Minimum sanitary conditions to be used without risks in the human body [2]. [...]the application of biopolymers and their adverse effects are considered a pathology called Iatrogenic Allogeneic, named in 2008 by Dr. Felipe Coffman, considered one of the pioneers in describing this pathology for the first time in Latin America, a plastic surgeon of Ukrainian nationality, but that all his life was eradicated in Colombia, thus being one of the main countries in the treatment and management of this pathology [3]. Polytetrafluoroethylene is also used, it is a polymer similar to polyethylene, it is used very frequently and it is biocompatible. [...]hyaluronic acid is preferred by most plastic surgeons due to its characteristics and biosafety. [...]the third is that most of the time they do not meet the minimum health control requirements, which increases the risk of complications and secondary effects due to infection. [...]the great number of substances used as body fillers will be very difficult to predict their behavior.